Salvatore Panduri

Pisa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Organization of skin ulcer outpatient clinics in Italy: results from a survey of the Study Group on Ulcers of the Italian Society of Dermatology and Venereology.

Organization of skin ulcer outpatient clinics in Italy: results from a survey of the Study Group on Ulcers of the Italian Society of Dermatology and Venereology.

Journal: Italian journal of dermatology and venereology

Published: August 26, 2026

Effectiveness of bimekizumab according to previous biologic exposure in patients with plaque psoriasis: a multicenter real-world study.

Effectiveness of bimekizumab according to previous biologic exposure in patients with plaque psoriasis: a multicenter real-world study.

Journal: The Journal of dermatological treatment

Published: July 29, 2026

Real-world effectiveness and predictors of complete skin clearance (PASI 100) with anti-IL-23 monoclonal antibodies in moderate-to-severe psoriasis: a retrospective cohort study.

Real-world effectiveness and predictors of complete skin clearance (PASI 100) with anti-IL-23 monoclonal antibodies in moderate-to-severe psoriasis: a retrospective cohort study.

Journal: Expert opinion on biological therapy

Published: November 03, 2025

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index.

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index.

Journal: The Journal of dermatological treatment

Published: September 24, 2025

Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study.

Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study.

Journal: Dermatology practical & conceptual

Published: August 31, 2025

Assessing the burden of dermatological diseases on work life from a gender perspective.

Assessing the burden of dermatological diseases on work life from a gender perspective.

Journal: Scientific reports

Published: March 23, 2025

Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational study.

Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational study.

Journal: Expert opinion on biological therapy

Published: March 20, 2025

Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric study.

Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric study.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: January 09, 2025

Risankizumab in very elderly patients in real-world practice.

Risankizumab in very elderly patients in real-world practice.

Journal: Italian journal of dermatology and venereology

Published: November 07, 2024

Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum.

Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum.

Journal: Advances in skin & wound care

Published: April 22, 2024

Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.

Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.

Journal: Archives of dermatological research

Published: April 21, 2024

Paradoxical Eczematous Eruptions in Patients with Psoriasis Treated with Biological Therapy.

Paradoxical Eczematous Eruptions in Patients with Psoriasis Treated with Biological Therapy.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: March 14, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026